Experimental LCL161 Combo Therapy Boosts Immunity and Shrinks Tumors in Myeloma Patients
By activating the immune system, the experimental drug LCL161 has the potential to fight myeloma in both mice and humans, according to a new study by…
News
Myeloma UK Launches Reolysin Combo Trial for Relapsing Myeloma Patients
The cancer charity Myeloma UK has launched a Phase 1 clinical trial testing Reolysin (pelareorep), a modulator of the immune system and cytotoxic agent, in myeloma…
Patient Power Backs Multiple Myeloma Patient’s Quest to Run 101st Marathon
Don Wright, who recently finished his 100th marathon while on active treatment for multiple myeloma, will continue running, but now with the support of the…
WT-1 Cancer Vaccine Could Benefit Myeloma Patients Undergoing Stem Cell Transplants
Multiple myeloma patients undergoing autologous stem cell transplants (ASCT) may strongly benefit from SELLAS‘ WT-1 cancer vaccine, galinpepimut-S, according to recent data from a…
Early Studies of 2 Possible Multiple Myeloma Treatments to Be Presented at AACR
GlycoMimetics will present preclinical research at the American Association for Cancer Research (AACR) Annual Meeting 2017, demonstrating the potential of two drug candidates,…
Celyad’s Trial Evaluating CAR T-cells in 7 Cancers to Start Enrolling Patients in US
Celyad is ready to enroll patients in its Phase 1 THINK trial in Rosewell Park, N.Y. and the University of Pittsburgh Medical Center in Pennsylvania after gaining…
Kyprolis Significantly Improved Survival of Relapsed Myeloma Patients in Phase 3 Study
Patients with relapsed or refractory multiple myeloma who receive a combination of Kyprolis (carfilzomib) and dexamethasone have significantly better survival rates than those receiving Velcade (bortezomib) plus…
Rabbit Virus Hammers Myeloma in Mice, but Human Use Is a Ways Off
A rabbit virus slowed the growth of multiple myeloma in mice, and eradicated the cancer in a fourth of the animals, a study reported. But…
Letermovir Prevents CMV Infection, Improves Survival in Bone Marrow Transplant Patients
Patients undergoing hematopoietic (donor) stem cell transplants could benefit from treatment with the experimental drug letermovir, which prevents the common viral infection cytomegalovirus (CMV). These results…
Finding That Immune Cells Interact Could Lead to Myeloma Therapies, Study Suggests
One kind of immune cell helps another stay active for years against invaders, a finding that could lead to therapies for autoimmune diseases and certain…
Recent Posts
- Treatment before surgery slows PDAC disease progression: Study
- Scientists discover tissue differences in brain cancer in children
- Elahere approved in EU as treatment for ovarian cancer
- Survival better with Blenrep combo than Darzalex for R/R myeloma
- Aucatzyl, a cell therapy, approved in US for adults with advanced B-ALL